Monday 27 March 2017

Duloxetine, venlafaxine, pregabalin, oxcarbazepine, tricyclic antidepressants, atypical opioids (e.g., tapentadol), and botulinum toxin are all more effective than placebo in reducing pain associated with diabetic peripheral neuropathy, according to a Neurology review

Duloxetine, venlafaxine, pregabalin, oxcarbazepine, tricyclic antidepressants, atypical opioids (e.g., tapentadol), and botulinum toxin are all more effective than placebo in reducing pain associated with diabetic peripheral neuropathy, according to a Neurology review

No comments: